These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 11597795)

  • 1. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.
    Ang KK; Trotti A; Brown BW; Garden AS; Foote RL; Morrison WH; Geara FB; Klotch DW; Goepfert H; Peters LJ
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):571-8. PubMed ID: 11597795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
    Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck.
    Rosenthal DI; Liu L; Lee JH; Vapiwala N; Chalian AA; Weinstein GS; Chilian I; Weber RS; Machtay M
    Head Neck; 2002 Feb; 24(2):115-26. PubMed ID: 11891941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck.
    Margalit DN; Haddad RI; Tishler RB; Chau NG; Schoenfeld JD; Bakst RL; Misiukiewicz KJ; Gupta V; Posner M; Hanna GJ; Mahmood U; Rawal B; Catalano PJ; Rath L; Bacay A; McHugh P; Rabinowits G
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):132-139. PubMed ID: 31082494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
    MacKenzie R; Balogh J; Choo R; Franssen E
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
    Kasperts N; Slotman BJ; Leemans CR; de Bree R; Doornaert P; Langendijk JA
    Cancer; 2006 Apr; 106(7):1536-47. PubMed ID: 16518815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck.
    Trotti A; Klotch D; Endicott J; Ridley M; Greenberg H
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):13-21. PubMed ID: 8482619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative radiation therapy (IORT) for head and neck cancer.
    Toita T; Nakano M; Takizawa Y; Sueyama H; Kakihana Y; Kushi A; Ogawa K; Hara R; Sunakawa H; Arasaki A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1219-24. PubMed ID: 7961032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
    Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
    Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
    Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas.
    Morris MM; Schmidt-Ullrich RK; DiNardo L; Manning MA; Silverman L; Clay L; Johnson CR; Amir C
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):918-28. PubMed ID: 11958884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
    Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.